Abstract
In Europe, Supplementary Protection Certificates have been available for human and veterinary medicinal products since 1993. Although certain fundamental issues surrounding them have been resolved, questions still remain about their scope and whether they can be obtained at all for some products. This article explores where we are now and what challenges lay ahead.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
